The International Society for Vaccines (ISV) is pleased to announce the 2021 ISV Annual Virtual Congress will take place on September 13 -15. The Congress will include pre-recorded and live sessions in different focus areas beginning with two keynote addresses and an introduction of the new ISV fellows, followed by multiple scientific sessions. While the exact details will be determined later, sessions will include executive summaries via pre-recorded tracks, live Q&A sessions with speakers, presentations selected from submitted abstracts, dedicated poster sessions, and a variety of highly interactive meetings. Participants will be able to meet and talk with their Fellow(s) of choice, select their favorite masterclass(es), and attend one or more workshops of interest.
We invite registrants to submit an abstract for a possible pre-recorded oral or poster presentation. Abstracts will be reviewed by our Scientific Committee (SC) outlined below. We also invite those who are interested in presenting a poster to submit a brief 2-3-minute introduction video once the SC accepts the abstract. The traditional Oral Abstract presentations selected by the SC will have the opportunity to give a 10-15 min presentation at one of the plenary sessions. Please scroll down to the abstract submission section for the link to instructions and to submit your abstract.
Additionally, selected outstanding oral and poster presentations from the Congress will be invited to contribute an article (Research paper, Review or Commentary) based on the presented work in a Special Issue of the journal Human Vaccines and Immunotherapeutics (HV&I) where previous ISV congress special issues are published.
Please check back regularly as we will be making continual updates on the agenda and Congress design.
We are looking forward to making this an unforgettable, exciting & interactive event!
Manon Cox on behalf of the co-chairs and scientific committee
Please pre-register for the 2021 ISV Annual Virtual Congress by clicking the registration button (free for pre-registration). You will receive your official login information via email upon completion. Be sure to save this information as you will need it to login to the Live Event.
The deadline to pre-register is September 1. Pre-registration now will allow you to receive all email updates related to Congress organization and preview the Congress design.
Attending the three-day ISV Annual Congress (September 13-15, 2021) is a paid event and registration rates are listed below. In addition to pre-registering, please choose your rate below (subject to verification) and click the associated link to complete your payment. If payment is not received your login will become deactivated and you will not be able to enter the Live Event on September 13-15th.
Active ISV members will receive a $100 discount to the listed registration fee (ISV one-year membership is $100). Student/postdoc members will receive a $35 discount (ISV one-year student membership is $35). We encourage everyone to become an ISV member to take advantage of the reduced rates and more member benefits. You may do so by visiting www.isv-online.org.
|Type of Delegates||Non-ISV Member||ISV Member|
ISV Non-Member Academic Rate
ISV Member Academic Rate
ISV Non-Member Industry Rate
ISV Member Industry Rate
ISV Non-Member Student Rate
ISV Member Student Rate
Please email firstname.lastname@example.org with any questions
Abstract submission is open now! The deadline for regular submission is July 20. The submission of an abstract is free but attending ISV 2021 Annual Virtual Congress requires paid registration. Please note the abstract process will be the same as our previous in-person Congresses. Once submitted, your abstract will be reviewed by the Scientific Committee. Based on their review a small percentage will be selected to give a pre-recorded oral presentation which will be included in the Congress program. Other accepted abstracts will be presented as posters for our virtual poster sessions. If you are selected for a poster presentation you have the option to include a 2–3-minute introduction video. More details on oral and poster abstracts will be announced in the weeks ahead. Please submit your abstract by clicking below. Be sure to follow the instructions noted at the top of the submission page.
DNA Delivery of Immune‐Focused SARS‐CoV‐2 Nanoparticle Vaccines Drives Rapid and Potent Immunogenicity and Achieves Single‐Dose Protection
An mRNA vaccine against SARS‐CoV‐2: Polyethylene Glycol‐free, liposome‐based vaccine candidate EG‐COVID induces high levels of virus neutralizing antibodies
Perception of Vaccination of Filipino Mothers in the NCR Area Post‐Dengvaxia
High Throughput Biosensor Technology to Establish Dosing Frequency and Concentration for an mRNA‐LNP Genital Herpes Vaccine
T Cell Epitope Content Comparison (EpiCC) Analysis Between PCV2 Vaccines and Field Strains
Improved Protection Against Multidrug Pseudomonas Aeruginosa Following Administration of an Fc Engineered DNA‐encoded Monoclonal Antibody (DMAb) with Enhanced Complement Activity